Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

被引:22
|
作者
Vena, Gino A. [1 ]
Cassano, Nicoletta [1 ]
Coco, Valeria [2 ]
De Simone, Clara [2 ]
机构
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Unit Dermatol & Venereol, I-70124 Bari, Italy
[2] Univ Cattolica Sacro Cuore, Unit Dermatol, I-00168 Rome, Italy
关键词
Antihypertensive drugs; cutaneous adverse drug reactions; drug-induced dermatitis; eczema; hydrochlorothiazide; CAPTOPRIL; DRUG; SURVEILLANCE; BRADYKININ; IRBESARTAN; ERUPTION;
D O I
10.3109/08923973.2013.797992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cutaneous adverse drug reactions (ADRs) to antihypertensive drugs have been frequently reported. We describe a peculiar clinical pattern of cutaneous ADR, represented by an eczematous reaction induced by certain antihypertensive drugs that we observed in elderly patients. The case series consisted of 23 hypertensive patients aged 66-87 years; 19 of them were taking another drug in addition to the suspected antihypertensive medication and 15 were on polytherapy with three or more drugs to treat multiple comorbidities. The antihypertensive culprit agents were angiotensin-converting enzyme (ACE) inhibitors in 9 patients, ACE-inhibitors combined to hydrochlorothiazide (HCT) in 7 subjects, angiotensin II receptor blockers alone in 2 patients and associated with HCT in 5 cases. The cutaneous ADR was characterized by an eczematous rash that was generalized in 16 patients and localized in 7 cases, with predominant involvement of lower limbs. Such lesions developed after a latency of 4-30 months and were associated with moderate-to-severe itch, usually unresponsive to oral antihistamines. Histopathological diagnosis was available for 9 cases, confirming the presence of a spongiotic dermatitis with possible associated psoriasiform skin changes.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 50 条
  • [21] Which prevents diabetes better: Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Elliott, WJ
    Choi, KL
    Arano, KG
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 57A - 58A
  • [22] Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?
    Kaplan, NM
    JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) : S87 - S90
  • [23] The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes
    Padwal, Raj
    Lin, Mu
    Eurich, Dean T.
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (03): : 200 - 206
  • [24] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport Reply
    Nessim, Sharon J.
    Perl, Jeffrey
    Bargman, Joanne M.
    KIDNEY INTERNATIONAL, 2011, 79 (01) : 137 - 137
  • [25] Effects of some angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on experimental inflammations
    Magyar, Ioan
    Cret, Mihai
    Cuparencu, Barbu
    FASEB JOURNAL, 2013, 27
  • [26] Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?
    NM Kaplan
    Journal of Human Hypertension, 2000, 14 : S87 - S90
  • [27] Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
    Mamdani, Muhammad
    Gomes, Tara
    Greaves, Simon
    Manji, Selina
    Juurlink, David N.
    Tadrous, Mina
    Kennedy, Sidney H.
    Antoniou, Tony
    JAMA NETWORK OPEN, 2019, 2 (10)
  • [28] The Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Postangioplasty Restenosis
    Liu, Ying
    Carrey, Zev
    Aronow, Wilbert S.
    Alaie, Daruish
    Petrillo, Richard L.
    Frishman, William H.
    AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (04) : e107 - e114
  • [29] Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice
    Barrios, Vivencio
    Coca, Antonio
    Escobar, Carlos
    Enrique, Rosa
    Miguel Rincon, Luis
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (02) : 159 - 166
  • [30] The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality
    Mourad, Jean-Jacques
    MAYO CLINIC PROCEEDINGS, 2016, 91 (07) : 972 - 972